Mark Oki has served as Achieve Life Sciences' Chief Financial Officer since December 2024. He was previously Chief Financial Officer of Aytu Biopharma, Inc. from January 2022 to November 2024 and Chief Financial Officer of Vivus LLC (formerly Vivus Inc.), a commercial-stage pharmaceutical company, from 2015 to January 2022. From 2006 to 2015 he held several positions at Alexza Pharmaceuticals, Inc., most recently as Senior Vice President, Finance, Chief Financial Officer and Secretary, and earlier held roles of increasing responsibility at Pharmacyclics, Inc. and Incyte Genomics, Inc. He began his career in public accounting at Deloitte & Touche. Mr. Oki holds a degree in Business Administration - Accounting from San Jose State University and is a Certified Public Accountant (inactive).